2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Prafull Ghatage, MD

Gynecologic Oncologist
Tom Baker Cancer Centre
1331 29 ST NW
Calgary, AB
Canada T2N 4N2

Papers:
8 A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)